Brief: Krystal Biotech Q2 Net Income USD -33.21 Million
07/08/2023 12:00
Aug 07 (Reuters) - Krystal Biotech Q2 basic EPS USD -1.25. * Q2 operating expenses USD 38.048 million * Q2 operating income USD -38.048 million
Recent news on Krystal Biotech
See all newsBrief: Krystal Biotech Announces Positive Clinical Data For New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression In Patients With Gorlin Syndrome
Krystal Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Krystal Biotech Q2 revenue rises on VYJUVEK strength
Brief: Krystal Biotech - Files Response With Uspto On Kb801 Patent Application - SEC Filing
Construction firm Tutor Perini jumps on S&P SmallCap inclusion